Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer Source: Eur Respir J 2015; 46: 1762-1772 Year: 2015
Distinct profiles of Th1 and Th2 cytokines in patients with IPF, CTD-ILD, and IPAF Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Evaluation expression of miR-146a and miR-155 and inflammatory cytokines in blood of non-small cell lung cancer patients Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
BAL-fluid profile of several pro-inflammatory, Th1, Th2 and B cell related cytochines in BOS patients Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010
Different Th1, Th2, Th17 and Treg associated chemokine local pattern expression in lung in a murine model of allergic inflammation Source: Annual Congress 2011 - T-cell subsets Year: 2011
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer Source: Eur Respir J 2007; 30: 627-632 Year: 2007
Pro-inflammatory cytokine changes in patients with cancer after BAL Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004
Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010
Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10 Source: Eur Respir J 2007; 30: 608-610 Year: 2007
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016
Differential cytokine expression in non-small cell lung carcinomas Source: Eur Respir J 2007; 30: Suppl. 51, 512s Year: 2007
Apoptosis of circulating and BALF lymphocytes of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004
Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-? Source: Eur Respir J, 57 (3) 2000983; 10.1183/13993003.00983-2020 Year: 2021
The level of IL-10, IL-12 and soluble Fas (sFas) in patients with non-advanced and advanced NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017
Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006
The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival Source: Eur Respir J 2009; 33: 118-126 Year: 2009